(1)
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES. Mediterr J Hematol Infect Dis 2026, 18 (1). https://doi.org/10.4084/MJHID.2026.022.